Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test

Journal of Hypertension

Volumn 19, Issue 3, 2001, Pages 495-502

  Astarita, Costantino ^a,b,c   Pálinkás, Attila ^a,b,c,d   Nicolai, Emanuele ^a,b,c   Maresca, Francesco Saverio ^a,b,c   Varga, Albert ^a,b,c   Picano, Eugenio ^a,b,c  

^a Servizio di Cardiologia Utic Ospedale di Sorrento Regione Campania ASL Na 5   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d George Soros Foundation

Author keywords

Coronary artery disease; Hypertension; Myocardial scintigraphy; Stress echocardiography

Indexed keywords

ATROPINE; DIPYRIDAMOLE; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EXERCISE ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; STRESS ECHOCARDIOGRAPHY;

EID: 0035120450     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200103000-00018     Document Type: Article

References (38)

1. How can we diagnose coronary heart disease in hypertensive patients?
2. ACC/AHA guidelines for the clinical application of echocardiography: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
3. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium 201 scintigraphy
4. Thallium-201 stress imaging in hypertensive patients
5. A negative thallium (± dipyridamole) stress test excludes significant obstructive epicardial coronary artery disease in hypertensive patients
6. Comparison of dobutamine stress echocardiography and technetium-99 m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy
7. Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with the dobutamine-atropine stress echocardiography: Effect of the left ventricular hypertrophy
8. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients
9. Technetium-99 m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain
10. Diagnostic accuracy of dobutamine stress echocardiography for detection coronary artery heart disease in hypertensive patients
11. Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools
12. Dipyridamole-echocardiography test in essential hypertensives with chest pain
13. Dipyridamole-echocardiography test in essential hypertensives with chest pare and angiographically normal coronary disease
14. ST segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patients
15. Hypertension and ischemic heart disease. Role of dipyridamole echocardiography test
16. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary artery disease in hypertensive patients with chest pain and positive exercise test
17. Pharmacologic stress echocardiography: Can we forget 'state-of-the-art' protocols?
18. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography
19. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers
20. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiographic measurements
21. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods
22. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography
23. The atropine factor in pharmacological stress echocardiography
24. Dipyridamole stress echocardiography: State of the art 1996
25. Pharmacologic stress echocardiography in the assessment of coronary artery disease
26. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
27. Stress echocardiography and the human factor: The importance of being expert
28. Madness and method in stress echo reading
29. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
30. Early impairment of coronary flow reserve in young men with borderline hypertension
31. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease
32. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram
33. Increased prevalence of ventricular arrhythmias in essential hypertensives with dipyridamole-induced ischemic-like ST segment changes
34. Lack of correlation between cardiac mass and arteriolar structural changes in mild to moderate hypertension
35. Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long term antihypertensive treatment
36. Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult hypertrophic cardiomyopathy
37. Isn't it time to reevaluate the sensitivity of noninvasive approaches for the diagnosis of coronary artery disease?
38. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials